Regenerative Medicine

NEW YORK, August 5, 2026 Lexeo Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative...

San Diego, California, August 5, 2026 NueCell Bio has officially launched as a specialized cell therapy science and development...

NEWTON, Mass., May 4, 2026 Satellite Bio announced that the U.S. Food and Drug Administration (FDA) has granted Rare...

Shanghai, China, August 4, 2026 AsymBio, the biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymchem...

Phoenix, Arizona, August 3, 2026 BioLab Holdings, Inc. has announced the publication of a peer-reviewed real-world evidence (RWE) study...

CHICAGO, July 30, 2026 EVERSANA has been selected by Innovacell Inc. as its exclusive U.S. commercialization partner to support...

NEW YORK, USA / MELBOURNE, Australia, July 29–30, 2026 Mesoblast Limited reported strong commercial and clinical progress for the...

CANTON, Mass., July 27, 2026 Organogenesis Holdings Inc. announced the publication of peer-reviewed clinical trial results demonstrating the effectiveness...

DURHAM, N.C., July 27, 2026 Humacyte, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted its...

RESEARCH TRIANGLE PARK, N.C., July 21, 2026 Merakris Therapeutics announced that it has received a Direct-to-Phase II Small Business...